At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 72 enrolled
Drug / intervention
etonogestrel implantdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetic and Pharmacodynamic Evaluation of Etonogestrel Dose Escalation With Efavirenz-based Antiretroviral Therapy in HIV-infected Ugandan
In Brief
A Phase 2 clinical trial evaluating etonogestrel implant for HIV/AIDS and Contraception. Completed, enrolled 72 participants across 1 site.
Detailed Summary
This study will evaluate the frequency of ovulation and cervical mucus quality of HIV-infected Ugandan women on efavirenz-based antiretroviral therapy using either a single etonogestrel implant or two etonogestrel implants for at least one year.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV/AIDS, Contraception
CountriesUganda
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartFeb 2019
Primary CompletionDec 2020
Study CompletionOct 2022
TodayJul 2026
First PostedSep 14, 2017
Enrollment StartFeb 19, 2019
Primary CompletionDec 22, 2020
Study CompletionOct 25, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.8 years ago
Interventions
etonogestrel implantdrug
The etonogestrel implant is an contraceptive implant that is placed into the upper arm.